Skip to main content
. 2019 Sep 27;39(10):642–649. doi: 10.1089/jir.2019.0013

FIG. 3.

FIG. 3.

Sustained virologic response rates of HCV genotype 3 patients receiving peg-IFN-α and Ribavirin (IFNRB) or DAA treatment by ethnic origin and IFNL4 rs368234815 genotypes. IFNRB_SVR (ΔG/ΔG versus ΔG/TT, or ΔG/TT versus TT/TT OR = 1.5, P = 2.3 × 10−7), DAA_SVR (ΔG/ΔG versus ΔG/TT, or ΔG/TT versus TT/TT OR = 1.7; P = 4.2 × 10−4), and log10(PTVL) (ΔG/ΔG versus ΔG/TT, or ΔG/TT versus TT/TT beta = −0.23, P = 8.8 × 10−10). IFNL, interferon lambda.